Metabolic Syndrome and Ischemic Stroke in Iran: Incidence and Disability-Adjusted Life Years 1990 to 2019
Metabolic Syndrome and Related Disorders · 2024
DOI: 10.1089/met.2023.0253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolic Syndrome and Related Disorders, 2024. Verfasst von Moslem Taheri-Soodejani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Healthcare Data Modeling, Departments of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sc…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Ischemic Stroke, Disability-Adjusted Life Years. Die Arbeit nennt 15 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Metabolic syndrome (MS) is one of the conditions that may increase the risk of ischemic stroke (IS). This study focuses on factors of MS related to the incidence, years of life lost (YLL), and years of life disability (YLD) caused by IS. Materials and Methods: The age-adjusted data (incidence, YLL, and YLD) related to four factors of MS [fasting plasma glucose, body mass index (BMI), low-density lipoprotein, and systolic blood pressure, SBP] were extracted as risk factors for IS during the years 1990 to 2019 from global burden of disease study. ARC GIS V.10 software was used to investigate the geographical distribution and the Cochran-Armitage test was used to investigate the trend of these indices.
Results
The highest incidence of IS was reported in Golestan provinces in 2019 [women: 180 (95% UI 153-213), men: 163 (95% UI 141-191), and both genders: 172 (95% UI 149-201)]. High SBP has the highest impact on YLD (96-102 per 100,000 population in some provinces) and YLL (688-824 per 100,000 population in some provinces) in men and women (YLD: 126-156, YLL: 586-785 per 100,000 population in some provinces). High BMI has increased YLD caused by IS from 1990 (35 per 100,000 population) to 2019 (53 per 100,000 population).
Conclusion
Considering the importance of IS and the impact that MS has on this disease, it seems that one of the most effective possible measures is to eliminate MS. The factors of MS are mostly related to lifestyle, and MS can be controlled with a suitable plan, which can be considered as primary prevention for IS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Healthcare Data Modeling, Departments of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Department of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Clinical Research Development Unit, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Seyyed-Mohammad Tabatabaei
Zitieren
APA
Taheri-Soodejani, M., Rasoulian-Kasrineh, M., & Tabatabaei, S. M. (2024). Metabolic Syndrome and Ischemic Stroke in Iran: Incidence and Disability-Adjusted Life Years 1990 to 2019. Metabolic Syndrome and Related Disorders. https://doi.org/10.1089/met.2023.0253
Vancouver
Taheri-Soodejani M, Rasoulian-Kasrineh M, Tabatabaei SM. Metabolic Syndrome and Ischemic Stroke in Iran: Incidence and Disability-Adjusted Life Years 1990 to 2019. Metabolic Syndrome and Related Disorders. 2024. doi:10.1089/met.2023.0253
BibTeX
@article{TaheriSoodejani2024,
author = {Taheri-Soodejani, Moslem and Rasoulian-Kasrineh, Marjan and Tabatabaei, Seyyed-Mohammad},
title = {Metabolic Syndrome and Ischemic Stroke in Iran: Incidence and Disability-Adjusted Life Years 1990 to 2019},
journal = {Metabolic Syndrome and Related Disorders},
year = {2024},
doi = {10.1089/met.2023.0253}
}
EUVIMED